Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Seres Therapeutics Inc MCRB

Healthcare Biotechnology
Seres Therapeutics, Inc. is a commercial-stage microbiome therapeutics company. It is focused on the development and commercialization of a novel class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. Its lead program, VOWST, is to prevent recurrence of... see more

Recent & Breaking News (NDAQ:MCRB)

EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire October 5, 2016

MCRB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Seres Therapeutics, Inc. and a Lead Plaintiff Deadline of November 28, 2016

GlobeNewswire October 5, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Seres Therapeutics, Inc. (MCRB) & Lead Plaintiff Deadline: November 28, 2016

GlobeNewswire October 5, 2016

SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire October 3, 2016

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Seres Therapeutics, Inc. - MCRB

Business Wire October 3, 2016

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

Business Wire October 3, 2016

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire October 1, 2016

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Seres Therapeutics, Inc. (MCRB)

GlobeNewswire September 30, 2016

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire September 30, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Seres Therapeutics, Inc. (MCRB) & Lead Plaintiff Deadline: November 28, 2016

PR Newswire September 30, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Seres Therapeutics, Inc. - MCRB

PR Newswire September 29, 2016

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Seres Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline

GlobeNewswire September 29, 2016

INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire September 29, 2016

UPDATE – SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Seres Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2016 – MCRB

GlobeNewswire September 28, 2016

SHAREHOLDER ALERT: Securities Class Action Lawsuit Against Seres Therapeutics Announced by Holzer & Holzer

Business Wire September 28, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Seres Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 29, 2016 – MCRB

GlobeNewswire September 28, 2016

Seres Therapeutics Reports Second Quarter Financial Results and Provides Operational Progress Update

Business Wire August 11, 2016

Earnings Scheduled For August 11, 2016

Benzinga.com  August 11, 2016

SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire August 5, 2016

INVESTOR ALERT: Investigation of Seres Therapeutics, Inc. Announced by Law Offices of Howard G. Smith

Business Wire August 5, 2016